Talphera (TLPH) Competitors

$0.89

0.00 (0.00%)

(As of 07/26/2024 ET)

TLPH vs. MURA, RMTI, ANEB, BRNS, VHAQ, VACC, AVTE, IMMX, ALRN, and HILS

Should you be buying Talphera stock or one of its competitors? The main competitors of Talphera include Mural Oncology (MURA), Rockwell Medical (RMTI), Anebulo Pharmaceuticals (ANEB), Barinthus Biotherapeutics (BRNS), Viveon Health Acquisition (VHAQ), Vaccitech (VACC), Aerovate Therapeutics (AVTE), Immix Biopharma (IMMX), Aileron Therapeutics (ALRN), and Hillstream BioPharma (HILS). These companies are all part of the "pharmaceutical preparations" industry.

Talphera vs.

Mural Oncology (NASDAQ:MURA) and Talphera (NASDAQ:TLPH) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, community ranking, valuation, media sentiment, analyst recommendations and risk.

: 80.2% of Mural Oncology shares are owned by institutional investors. Comparatively, 37.7% of Talphera shares are owned by institutional investors. 0.1% of Mural Oncology shares are owned by company insiders. Comparatively, 3.0% of Talphera shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
: Mural Oncology currently has a consensus target price of $14.00, suggesting a potential upside of 300.00%. Talphera has a consensus target price of $4.50, suggesting a potential upside of 408.02%. Given Mural Oncology's higher probable upside, analysts clearly believe Talphera is more favorable than Mural Oncology.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mural Oncology
0 Sell rating(s)
0 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
3.00
Talphera
0 Sell rating(s)

0 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
3.00
: Talphera's return on equity of 0.00% beat Mural Oncology's return on equity.
Company Net Margins Return on Equity Return on Assets
Mural Oncology N/A N/A N/A
Talphera N/A -96.30% -63.20%
: In the previous week, Mural Oncology had 6 more articles in the media than Talphera. MarketBeat recorded 8 mentions for Mural Oncology and 2 mentions for Talphera. Mural Oncology's average media sentiment score of 1.44 beat Talphera's score of 0.22 indicating that Talphera is being referred to more favorably in the news media.
Company Overall Sentiment
Mural Oncology Neutral
Talphera Positive
: Talphera has higher revenue and earnings than Mural Oncology.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Mural Oncology N/A N/A -$207.45M N/A N/A
Talphera $650K 23.15 -$18.40M -$0.89 -1.00
: Talphera received 2 more outperform votes than Mural Oncology when rated by MarketBeat users.
Company Underperform Outperform
Mural Oncology Outperform Votes
2
100.00%
Underperform Votes
No Votes
Talphera Outperform Votes
4
100.00%
Underperform Votes
No Votes

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mural Oncology	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Talphera	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Company	Net Margins	Return on Equity	Return on Assets
Mural Oncology	N/A	N/A	N/A
Talphera	N/A	-96.30%	-63.20%

Company	Overall Sentiment
Mural Oncology	Neutral
Talphera	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mural Oncology	N/A	N/A	-$207.45M	N/A	N/A
Talphera	$650K	23.15	-$18.40M	-$0.89	-1.00

Company	Underperform	Outperform
Mural Oncology	Outperform Votes 2 100.00%	Underperform Votes No Votes
Talphera	Outperform Votes 4 100.00%	Underperform Votes No Votes

Summary

Talphera beats Mural Oncology on 6 of the 10 factors compared between the two stocks.

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

Get Talphera News Delivered to You Automatically

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TLPH vs. The Competition

Export to Excel

Metric	Talphera	Pharmaceutical Industry	Medical Sector	NASDAQ Exchange
Market Cap	$15.05M	$7.09B	$5.32B	$8.21B
Dividend Yield	N/A	2.82%	2.72%	3.97%
P/E Ratio	-1.00	21.83	157.66	18.66
Price / Sales	23.15	318.38	2,090.54	91.84
Price / Cash	N/A	32.58	35.75	34.11
Price / Book	1.07	5.89	4.95	4.51
Net Income	-$18.40M	$148.11M	$112.16M	$216.36M
7 Day Performance	1.82%	2.90%	2.71%	1.82%
1 Month Performance	-2.66%	9.06%	6.96%	7.09%
1 Year Performance	N/A	4.24%	11.17%	4.89%

Talphera Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MURA Mural Oncology	3.6194 of 5 stars 3.62 / 5 stars	$3.46 +0.9%	$14.00 +304.6%	N/A	$58.05M	N/A	0.00	119	Short Interest ↓ News Coverage
RMTI Rockwell Medical	4.4189 of 5 stars 4.42 / 5 stars	$1.85 -2.1%	$7.00 +278.4%	-46.6%	$57.45M	$83.61M	-5.14	300	Short Interest ↓ Positive News
ANEB Anebulo Pharmaceuticals	2.1297 of 5 stars 2.13 / 5 stars	$2.20 -8.3%	$6.67 +203.0%	-2.2%	$57.05M	N/A	-5.95	2	Positive News Gap Up
BRNS Barinthus Biotherapeutics	1.9116 of 5 stars 1.91 / 5 stars	$1.46 +0.7%	$5.50 +276.7%	N/A	$56.60M	$800,000.00	-0.79	107	Short Interest ↑ News Coverage
VHAQ Viveon Health Acquisition	0 of 5 stars 0.00 / 5 stars	$10.00 flat	N/A	N/A	$56.56M	N/A	0.00	N/A
VACC Vaccitech	1.3798 of 5 stars 1.38 / 5 stars	$1.45 flat	$7.63 +425.9%	-36.5%	$55.89M	$13.42M	-1.01	33	News Coverage
AVTE Aerovate Therapeutics	3.4039 of 5 stars 3.40 / 5 stars	$1.92 +1.6%	$2.25 +17.2%	-88.0%	$55.33M	N/A	-0.63	20	Short Interest ↓ Positive News Gap Up
IMMX Immix Biopharma	2.6863 of 5 stars 2.69 / 5 stars	$2.15 +4.4%	$10.50 +388.4%	+9.8%	$54.41M	N/A	-2.31	9	Analyst Forecast News Coverage Positive News
ALRN Aileron Therapeutics	2.3758 of 5 stars 2.38 / 5 stars	$2.51 -5.3%	$19.00 +657.0%	+37.1%	$54.24M	N/A	-0.79	15	Short Interest ↑
HILS Hillstream BioPharma	0 of 5 stars 0.00 / 5 stars	$3.08 -1.6%	N/A	+790.9%	$54.22M	N/A	-4.28	1	Gap Up